Indeed, platelets of COVID-19 patients seem capable of interacting with SARS-CoV-2 via ACE-2-independent mechanisms and upon contact with the virus, increase the secretion of GPVI, CXCL4 and CCL5 in vitro, as well as surface expression of P-selectin (172). Here, CCL5 is linked to COVID-19.